In this seminar from former U.S. Department of Justice Attorney Michael Johnson, you will learn about the hundreds of research studies scientists have conducted to best interview witnesses and assess credibility.
Correction
In a recent post in the Filing Cabinet, we incorrectly connected a recent enforcement action against Theranos founder and CEO Elizabeth Holmes with Mylan, the maker of the EpiPen.
Any implication or connection between the two companies was incorrect. Mylan had no connection to the SEC release.
Compliance Week regrets the error.
The PCAOB fined two EY partners for “failing to perform adequate procedures and obtain sufficient evidence” in connection with the Big Four firm’s audit of New Jersey software company Synchronoss Technologies.
Federal Reserve Chair Jerome Powell said Wells Fargo’s asset cap will remain in place until the bank has “comprehensively” fixed its governance and compliance deficiencies.
Companies have until the end of the year to stop making misleading claims about the green credentials of their products and services or face regulatory action, the U.K. Competition and Markets Authority has warned.
No comments yet